Rotbain Curovic, Viktor http://orcid.org/0000-0002-4270-6701
Hansen, Tine W.
Eickhoff, Mie K.
von Scholten, Bernt Johan
Reinhard, Henrik
Jacobsen, Peter Karl
Persson, Frederik
Parving, Hans-Henrik
Rossing, Peter
Funding for this research was provided by:
European Foundation for the Study of Diabetes
Article History
Received: 22 May 2018
Accepted: 2 August 2018
First Online: 14 August 2018
Compliance with ethical standards
:
: F. P. reports having received research Grants from Astra Zeneca, lecture fees from Astra Zeneca, MSD, Janssen, Lily, Boehringer Ingelheim, Novo Nordisk, Novartis and being consultant/advisory board member for Astra Zeneca, Bayer, Amgen and MSD. P. R. received lecture fees from Bayer and Boehringer Ingelheim, and research Grant from Novartis, Astra Zeneca, Novo Nordisk and has served as a consultant for Bayer, Astra Zeneca, Astellas, Boehringer Ingelheim, AbbVie, Novo Nordisk (all honoraria to his institution) and having equity interest in Novo Nordisk. The results presented in this paper have not been published previously in whole or part, except in abstract format.
: All procedures have been in accordance to ethical standards and ethical law, were applied, including the 1964 Declaration of Helsinki and the guidelines for Good Clinical Practice.
: All subjects in the study gave their informed and signed consent prior to inclusion.